• 29 September 2011

    AstraZeneca settles Seroquel XR dispute

    AstraZeneca has won its fight to prevent Handa Pharmaceuticals from selling a generic version of its anti-psychotic drug Seroquel XR in the US until late 2016.

  • 28 September 2011

    AstraZeneca Faslodex wins Japanese regulatory approval

    AstraZeneca has received Japanese regulatory approval for Faslodex (fulvestrant) 500mg, an oestrogen receptor antagonist for the treatment of postmenopausal women with hormone receptor-positive metastatic breast cancer.

Go Top